Skip to main content

Congratulations to Hayam Giravi, PharmD for publishing her PharmD research project

Jun 23, 2022

Congratulations to Hayam Giravi, PharmD

Congratulations to Hayam Giravi, PharmD, our freshly graduated student, for publishing her PharmD research project on combining opioid-based analgesia with digital health technologies. She is the first and co-corresponding author on an article “Adjunct Digital Interventions Improve Opioid-Based Pain Management: Impact of Virtual Reality and Mobile Applications on Patient-Centered Pharmacy Care” published in Frontiers in Digital Health.  Here is the link to this open-access paper:

Hayam’s PharmD research project was focused on reviewing randomized controlled trials (RCTs) of adjunct digital interventions (VR and mobile apps) for opioid-based analgesia. The goal of this collaborative article was to share awareness about integration of pharmacotherapies with digital therapeutics, and how such drug+digital combination therapies can impact patient-centered pharmacy care. This publication is very timely, given that the Food and Drug Administration (FDA) has authorized to market a prescription digital therapeutic (virtual reality app, called RelieVRx) for chronic low back pain, as well as a prescription adjunct digital therapeutic (mobile medical app, reSET-O) in conjunction with buprenorphine for opioid use disorder (OUD). 

Hayam Giravi